St. Michael’s researcher receives inaugural national award
St. Michael’s Dr. Andreas Laupacis, executive director of the Li Ka Shing Knowledge Institute, has been honoured with a prestigious national award for his work in assessing drugs, health technologies and systems that will improve health outcomes for Canadians.
Toronto, April 27, 2010
Dr. Laupacis was presented with the inaugural Dr. Jill M. Sanders Award of Excellence in Health Technology Assessment by the Canadian Agency for Drugs and Technologies in Health for his leadership in advancing health technology assessment. Health technology assessment evaluates the clinical and/or cost effectiveness of drugs or health technologies and systems in an effort to improve the quality of health care in Canada.
“It is a huge and humbling honour to receive an award named for Jill Sanders who had a real passion for health quality assessment,” said Dr. Laupacis. “By answering difficult questions about health technologies or drugs and assessing evidence-based policies, we can ensure we are providing the best care possible for Canadians.”
The Canadian Agency for Drugs and Technologies in Health is an independent, not-for-profit agency funded by Canadian federal, provincial and territorial governments. It aims to provide credible, impartial advice and evidence-based information about the effectiveness of drugs and other health technologies to Canadian health care decision-makers.